{"symbol":"ABT","fiscalQuarter":"Q2-2022","reportDate":"2022-07-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2022","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 1.55%","keyNumbers":[{"metric":"EPS","actual":"$1.43","expected":"N/A","surprise":"+34.15%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported a strong earnings per share, beating expectations significantly. However, the stock declined by 1.55% following the announcement. This reaction may indicate investor concerns or uncertainty despite the positive EPS surprise.","metaDescription":"Abbott Laboratories (ABT) Q2 2022 earnings: EPS beat by 34.15%. Stock down 1.55%. Full breakdown."}}